Effects of low power laser in maxillofacial disorders recovery

How to Cite:Ali Ghanjalmonireh motaqheyrahmatollah hafezimohammad ghasemiEffects of low power laser in maxillofacial disorders recovery.koomesh.17(3):e151202.

Abstract

Introduction: Maxillofacial disorders can lead to functional limitation and pain in head and face. Despite the high prevalence of this disorder, quite a few studies have performed in relation to that . The aim of this study was to investigate the effects of He-Ne low power laser (with a wavelength of 632.8nm ) in treatment of maxillofacial disorders. Materials and Methods: This study was a randomized clinical trial participating 142 patients with maxillofacial abnormalities, randomly divided to 2 groups of 71experimental and control participants. Background information about the degree of pain was obtained through a questionnaire and VAS (visual analog scale). Experimental and control groups were irradiated with He-Ne low level laser (632.8 nm wavelength, with the average intensity of 2.5 and zero joules per square centimeter) for 12 sessions (3 times a week, each time for 15min). The data related to before and after treatments and the change in percentages were analyzed. Results: before and after treatment, analysis showed significant relief in maxillofacial pain and movement limitations (P=0.013) in the experimental group. Comparisons between groups showed significant improvement in recovery of maxillofacial disorders of experimental against control (P=0.003).Comparing the difference in change percentage in the experimental and control groups was significant (P=0.001). Conclusion: He-Nelow power laser (within the wavelength of 632.8nm) can be considerably helpful to relief maxillofacial disorder’s disability and discomfort

Keywords

References

1.
Parker J. The effects of laser therapy on tissue repair and pain control: a meta-analysis of the literature. Proc. Third Congress World Assn for Laser Therapy, Athens, Greece 2000; May 10-13: 77.
2.
Johansson A, Unell L, Carlsson GE, Sderfeldt B, Halling A. Gender difference in symptoms related to temporomandibular disorders in a population of 50-year-old subjects. J Orofac Pain 2003; 17: 29-35.
3.
Pinheiro AL, Cavalcanti ET, Pinheiro TI, Alves MJ, Manzi CTLow-level laser therapy in the management of disorders of the maxillofacial region. Clin Laser Med Surg 1997; 15: 181-183.
4.
Bouneko JM. The efficacy of laser therapy in the treatment of wounds: a meta-analysis of the literature. Proc. Third Congress World Assn for Laser Therapy, Athens, Greece2000; May 10-13: 79.
5.
Kireev AK, Evstigneev AR, Voroshnin PA, Aleksandrov MT. The use of the Uzor laser apparatus for treating inflammatory diseases of the maxillofacial area. Stomatologiia (Mosk) 1989; 68: 42-45.
6.
Zhou GY, Shen LY, Tian KB, Zhang ZY, Liang JY, Zhu YL, Chan JA. [Treatment of 113 oral and maxillofacial hemangiomas with long pulsed turnable 1064 nm Gentle YAG laser]. Shanghai Kou Qiang Yi Xue 2006; 15: 250-253.
7.
Fikckov H, Dostlov T, Navrtil L, Klaschka J. Effectiveness of low-level laser therapy in temporomandibular joint disorders: a placebo-controlled study. Photomed Laser Surg 2007; 25: 297-303.
8.
Yoffe T, Shohat I, Shoshani Y, Taicher S. Etiology of maxillofacial trauma--a 10-year survey at the Chaim Sheba Medical Center, Tel-Hashomer. Harefuah 2008; 147: 192-196, 280.
9.
Pinheiro A. Low-level laser therapy is an important tool to treat disorders in the maxillofacial region. J Clin Laser Med Surg 1998; 16: 223-226.
10.
Ebneshahidi NS, Heshmatipour M, Moghaddami A, Eghtesadi-Araghi P. The effects of laser acupuncture on chronic tension headache--a randomised controlled trial. Acupunct Med 2005; 23: 13-18.
11.
Gross AR, Dziengo S, Boers O, Goldsmith CH, Graham N, Lilge L, Burnie S, White R. Low level laser therapy (LLLT) for neck pain: a systematic review and meta-regression. Open Orthop J 2013; 7: 396-419.
12.
Chow RT, Johnson MI, Lopes-Martins RA, Bjordal JM. Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials. Lancet 2009; 374: 1897-1908.
13.
Salmos-Brito JA, de Menezes RF, Teixeira CE, Gonzaga RK, Rodrigues BH, Braz R, et al. Evaluation of low-level laser therapy in patients with acute and chronic temporomandibular disorders. Lasers Med Sci 2013;; 28: 57-64.
14.
Cetiner S, Kahraman SA, Yceta S. Evaluation of low-level laser therapy in the treatment of temporomandibular disorders. Photomed Laser Surg 2006; 24: 637-641.
15.
Ahrari F, Madani AS, Ghafouri ZS, Tunr J. The efficacy of low-level laser therapy for the treatment of myogenous temporomandibular joint disorder. Lasers Med Sci 2014; 29: 551-557.
16.
Fikckov H, Dostlov T, Navrtil L, Klaschka J. Effectiveness of low-level laser therapy in temporomandibular joint disorders: a placebo-controlled study. Photomed Laser Surg 2007; 25: 297-303.
17.
Maia ML, Bonjardim LR, Quintans Jde S, Ribeiro MA, Maia LG, Conti PC. Effect of low-level laser therapy on pain levels in patients with temporomandibular disorders: a systematic review. J Appl Oral Sci 2012; 20: 594-602.
18.
Falaki F, Nejat AH, Dalirsani Z. The effect of low-level laser therapy on trigeminal neuralgia: a review of literature. J Dent Res Dent Clin Dent Prospects 2014; 8: 1-5.
19.
Madani AS, Ahrari F, Nasiri F, Abtahi M, Tunr J. Low-level laser therapy for management of TMJ osteoarthritis. Cranio 2014; 32: 38-44.
20.
Petrucci A, Sgolastra F, Gatto R, Mattei A, Monaco A. Effectiveness of low-level laser therapy in temporomandibular disorders: a systematic review and meta-analysis. J Orofac Pain 2011; 25: 298-307.
21.
Emshoff R, Bsch R, Pmpel E, Schning H, Strobl H. Low-level laser therapy for treatment of temporomandibular joint pain: a double-blind and placebo-controlled trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105: 452-456.

comments